Roszdravnadzor-2021-0079-V179
Type IB variation for application Roszdravnadzor-2021-0079. Type IB variation: Facility Change for Atezolimumab-R — major revision
Variation Number
Roszdravnadzor-2021-0079-V179
Type
Type IB
Application
Change
Status
Draft
Fee
€2,345
Submitted
2023-08-16
Approved
—
Description
Type IB variation: Facility Change for Atezolimumab-R — major revision